Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ARMP Stock Annual Income Statement. Download in Excel

Armata Pharmaceuticals Inc. logo

Armata Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

1.23
 
USD
  
0.05
  
(4.24%)
Previous close: 1.18  Open: 1.25  Bid: 1.19  Ask: 3.55
52 week range    
0.90   
   3.45
Mkt Cap: 42 M  Avg Vol (90 Days): 14,997
Last updated: Sunday 20th April 2025

Stock Rankings

29
MarketXLS Rank
40
Value
18
Technical
31
Quality
How are these ranks calculated?
Search for a stock

Financials

ARMP Income Statement

Annual
Dec-14Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23Dec-24
AccretionOnPreferredStock1 M2 M
AccruedPreferredStockDividends4 M
AcquiredInProcessRnD9 M2 M1 M
Amortization of intangibles-31000.03 M
Basic EPS from continuing operations-1.35-0.96-1.08-1.91-0.52
Basic EPS total1.68-9.8-28.14-8.96-2.49-1.35-0.96-1.08-1.91-0.52
Basic weighted shares outstanding13 M702746.0456244.01 M8 M16 M24 M34 M36 M36 M
Depreciation-127000.0-338000.0-343000.0-1 M-1 M1 M1 M900000.01000000.01 M
DepreciationAndAmortization-127000.0-338000.0-343000.0-1 M-1 M1 M1 M900000.01000000.01 M
Diluted EPS total0.98-34.58-30.52-8.96-2.55-1.35-0.96-1.08-1.91-0.89
Diluted normalized net income/share-1.35-0.96-1.08-1.91-0.89
Diluted weighted shares outstanding23 M544765.0469579.01 M8 M16 M24 M34 M36 M59 M
GainOnSaleOfPPE-663000.0
GeneralAndAdministrativeExpense7 M8 M8 M3 M9 M8 M8 M7 M12 M13 M
Gross operating profit409000.0260000.0115000.01 M823000.04 M6 M5 M5 M
ImpairmentOfCapitalAssets10 M6 M2 M
Income before tax23 M-19 M-14 M-17 M-19 M-22 M-23 M-37 M-69 M-19 M
Income restructuring and M&A2 M28 M21 M
Income taxes-556000.0-1 M-328000.0
Interest income245000.096000.028000.05000.029000.0179000.0
InterestExpenseNonOperating1000000.0931000.0600000.064000.03 M
MiscOtherSpecialCharges28 M-554000.0-6000.0184000.0-9000.0829000.05 M6 M-2 M-3 M
Net income from total operations23 M-19 M-15 M-17 M-19 M-22 M-23 M-37 M-69 M-19 M
NetIncomeCommonStockholders22 M-24 M-15 M-17 M-19 M-22 M-23 M-37 M-69 M-19 M
NetIncomeContinuousOperations23 M-19 M-15 M-17 M-19 M-22 M-23 M-37 M-69 M-19 M
NetNonOperatingInterestIncomeExpense2 M-755000.0-835000.0-572000.0-95000.029000.02 M
Normalized income-19 M
Operating income-12 M-14 M-10 M-18 M-19 M-22 M-24 M-37 M-41 M-42 M
Operating income before depreciation (EBITDA)23 M-19 M-14 M-14 M-17 M-20 M-22 M-36 M-68 M-18 M
OperatingExpense-15 M-24 M-16 M-18 M-20 M22 M28 M37 M45 M48 M
Other income net-28 M-4 M6000.0-86000.0672000.0-829000.0-5 M-6 M24 M-29 M
OtherGandA7 M8 M8 M3 M9 M8 M8 M7 M12 M13 M
OtherOperatingExpenses-15 M-24 M7 M2 M3 M6 M45 M48 M
OtherunderPreferredStockDividend1 M5 M
PreferredStockDividends1 M5 M
RealizedCapitalGain5 M-22 M31 M
RentAndLandingFees7 M8 M8 M3 M9 M
Research & development expense6 M6 M3 M8 M10 M14 M20 M35 M34 M34 M
ResearchExpense6 M6 M3 M8 M10 M14 M20 M35 M34 M34 M
RestructringAndMnAIncome2 M28 M21 M
Revenue per share-31000.03 M
SalariesAndWages-2 M-2 M-700000.0-46000.0-4 M-823000.0938000.03 M
Selling Gen & administrative expense7 M8 M8 M3 M9 M8 M8 M7 M12 M13 M
Special income/charges8 M-10 M-6 M2 M1 M
Total Income available for interest expense (EBIT)23 M-19 M-14 M-16 M-19 M-22 M-23 M-37 M-69 M-19 M
Total common shares outstanding39706.0117772.0978273.02 M11 M25 M31 M36 M36 M36 M
Total net income23 M-19 M-15 M-17 M-19 M-22 M-23 M-37 M-69 M-19 M
Total ordinary shares36 M36 M36 M36 M36 M36 M36 M36 M36 M36 M
Total revenues409000.0260000.0115000.01 M823000.04 M6 M-22 M5 M
TotalExpenses-15 M-24 M-16 M-18 M-20 M22 M28 M37 M45 M48 M
TotalRevenue409000.0260000.0115000.01 M823000.04 M6 M5 M5 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader